Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-03-30 Sale | 2021-04-01 8:00 pm | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 6,000 | $2.23 | $13,380 | 81,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-07-08 6:25 pm | N/A 2029-09-01 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 0 | $0 | 219,892 (Direct) | View |
2021-03-30 Exercise | 2021-04-01 8:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 6,000 | $0 | 81,900 (Direct) | View |
2021-03-30 Exercise | 2021-04-01 8:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 6,000 | $0.6919 | 81,900 (Direct) | View |
2021-03-15 Option Award | 2021-04-01 8:00 pm | N/A 2031-03-15 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 42,700 | $0 | 81,900 (Direct) | View |
Ownership | 2021-01-22 4:30 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 0 | $0 | 145,200 (Direct) | View |